(Q36055990)

English

Mucosal adjuvants

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

Mucosal adjuvants. (English)

1 reference

Europe PubMed Central

11 August 2017

author name string

Freytag LC

1

1 reference

Europe PubMed Central

11 August 2017

Clements JD

2

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

23

1 reference

Europe PubMed Central

11 August 2017

1804-1813

1 reference

Europe PubMed Central

11 August 2017

15

1 reference

Europe PubMed Central

11 August 2017

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

The role of Th1 and Th2 cells for mucosal IgA responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: role of COOH-terminal KDEL

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Cholera toxin is exported from microsomes by the Sec61p complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Protein Disulfide Isomerase Acts as a Redox-Dependent Chaperone to Unfold Cholera Toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

ARF binds the C-terminal region of the Escherichia coli heat-labile toxin (LTA1) and competes for the binding of LTA2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Vaccination against Helicobacter pylori in non-human primate models and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Induction of systemic immune responses to measles virus synthetic peptides administered intranasally

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Characterization of the antibody response to pneumococcal glycoconjugates and the effect of heat-labile enterotoxin on IGg subclasses after intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mutation of a buried residue causes loss of activity but no conformational change in the heat-labile enterotoxin of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Functional mapping of protective domains and epitopes in the rotavirus VP6 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Active immunity and T-cell populations in pigs intraperitoneally inoculated with baculovirus-expressed transmissible gastroenteritis virus structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Cholera toxin adjuvant greatly promotes antigen priming of T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Phospholipase A2 activating protein and idiopathic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Immunomodulation using bacterial enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Inhibition of T-cell response by Escherichia coli heat-labile enterotoxin-treated epithelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Epithelial cells as sensors for microbial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Contribution of the ADP-ribosylating and receptor-binding properties of cholera-like enterotoxins in modulating cytokine secretion by human intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Collaboration of epithelial cells with organized mucosal lymphoid tissues.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Activation of the immune system by bacterial CpG-DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Induction of intestinal IgA and IgG antibodies preventing adhesion of verotoxin-producing Escherichia coli to Caco-2 cells by oral immunization with liposomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Targeting polymerised liposome vaccine carriers to intestinal M cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.010

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.11.010

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36055990&oldid=1998797665"